United States > 3M News Center > Press Releases > Company >
- Date
- 2020-04-30
Summary
Exhibit A, filed April 30, 2020 as Document 1-1 in Case 8:20-cv-01003-MSS-CPT, is a six-page printout of a 3M News Center press release. The release, dated Monday, April 6, 2020 from St. Paul, announces a plan by 3M and the Trump Administration to import 166.5 million respirators into the United States over the next three months, primarily from 3M's manufacturing facility in China. It states that the imports supplement the 35 million N95 respirators 3M produces in the U.S. each month and quotes the company's chairman on the plan and on fighting price gouging and counterfeiting. The release also states that 3M doubled global N95 output to 1.1 billion per year and includes forward-looking statement disclosures and website navigation text.
Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used
Full text
Case 8:20-cv-01003-MSS-CPT Document 1-1 Filed 04/30/20 Page 1 of 6 PageID 30
EXHIBIT A
Case 8:20-cv-01003-MSS-CPT Document 1-1 Filed 04/30/20 Page 2 of 6 PageID 31
We use cookies on this site to enhance your user
experience.
OK, I agree
By clicking OK you are giving your consent for us to
set cookies.
PRODUCTS FOR PRODUCTS FOR ABOUT US
BUSINESS CONSUMERS
United States > 3M News Center > Press Releases > Company >
3M and the Trump Administration Announce Plan to Import 166.5 Million Additional Respirators into the United States over the Next Th
3M News Center
PRESS RELEASES 3M STORIES RESOURCES ABOUT 3M MEDIA CONTACTS
3M and the Trump Administration Announce Plan to Import 166.5 Mi
United States over the Next Three Months
Imports to supplement the 35 million N95 respirators 3M currently produces in U.S. per month
Monday, April 6, 2020 5:58 pm CDT
Dateline: ST. PAUL, Minn.
Public Company Information:
NYSE: MMM
Case 8:20-cv-01003-MSS-CPT Document 1-1 Filed 04/30/20 Page 3 of 6 PageID 32
ST. PAUL, Minn.--(BUSINESS WIRE)--Today 3M and the Trump Administration are announcing a plan to import 166
over the next three months to support healthcare workers in the United States. 3M and the Administration worked t
that this plan does not create further humanitarian implications for countries currently ghting the COVID-19 outbre
to further collaborate to ght price gouging and counterfeiting.
“I want to thank President Trump and the Administration for their leadership and collaboration,” said 3M chairman a
Roman. “We share the same goals of providing much-needed respirators to Americans across our country and comb
seek to take advantage of the current crisis. These imports will supplement the 35 million N95 respirators we curren
month in the United States.”
“Given the reality that demand for respirators outpaces supply, we are working around the clock to further expand o
the most critical areas,” Roman continued. “We’ll continue to do all we can to protect our heroic healthcare workers
your tireless e orts – including those in our plants and distribution centers around the world.”
3M will import 166.5 million respirators over the next three months primarily from its manufacturing facility in China
address and remove export and regulatory restrictions to enable this plan. The plan will also enable 3M to continue
where 3M is the primary source of supply.
As a global company, 3M has manufacturing operations around the world to serve local and regional markets. As th
continue to work with governments to direct respirators and other supplies to serve areas most in need.
Beginning in January, 3M ramped up production of N95 respirators and doubled its global output to 1.1 billion per ye
already put into motion additional investments and actions that will enable it to double its capacity again to 2 billion
online in the next 60 to 90 days. In the United States, for example, 3M expects to be producing N95 respirators at a
current levels.
Last week 3M announced additional actions to address price gouging and counterfeit activity related to its respirato
take decisive action against those seeking to take illegal and unethical advantage of the COVID-19 outbreak.
Forward-Looking Statements
This news release contains forward-looking information about 3M's nancial results and estimates and business pro
identify these statements by the use of words such as "anticipate," "estimate," "expect," "aim," "project," "intend," "p
other words and terms of similar meaning in connection with any discussion of future operating or nancial perform
cause actual results to di er materially are the following: (1) worldwide economic, political, regulatory, capital mark
Company's control, including natural and other disasters or climate change a ecting the operations of the Company
crises such as the global pandemic associated with the coronavirus (COVID-19); (3) liabilities related to certain uor
products and chemistries, and claims and governmental regulatory proceedings and inquiries related to PFAS in a v
developments that could occur in the legal and regulatory proceedings described in the Company's Annual Report o
quarterly reports on Form 10-Q (the “Reports”); (5) competitive conditions and customer preferences; (6) foreign cu
and market acceptance of new product o erings; (8) the availability and cost of purchased components, compound
derivatives) due to shortages, increased demand or supply interruptions (including those caused by natural and othe
with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and oth
infrastructure; (10) the impact of acquisitions, strategic alliances, divestitures, and other unusual events resulting fro
strategies, and possible organizational restructuring; (11) operational execution, including scenarios where the Comp
(12) nancial market risks that may a ect the Company’s funding obligations under de ned bene t pension and pos
of capital. Changes in such assumptions or factors could produce signi cantly di erent results. A further description
Concerning Factors That May A ect Future Results" and "Risk Factors" in Part I, Items 1 and 1A (Annual Report) and
by applicable Current Reports on Form 8-K. The information contained in this news release is as of the date indicate
looking statements contained in this news release as a result of new information or future events or developments.
Case 8:20-cv-01003-MSS-CPT Document 1-1 Filed 04/30/20 Page 4 of 6 PageID 33
About 3M
At 3M, we apply science in collaborative ways to improve lives daily. With $32 billion in sales, our 96,000 employe
3M’s creative solutions to the world’s problems at www.3M.com or on Twitter @3M or @3MNews.
Contact:
Jennifer Ehrlich
651-733-8805
Related Materials
Download press release as a PDF
Multimedia Files:
Download All Files
Download:
Download Thumbnail (33.12 KB)
Download Preview (34.23 KB)
Download Small (35.65 KB)
Download Square (34.4 KB)
3M United States
PRESS 3M NEWS RELATED HELP
RELEASES CENTER LINKS
Help Center
Company Media Investor
Site Map
Contacts Relations
Earnings and
Dividends 3M Stories History NEWS
Case 8:20-cv-01003-MSS-CPT Document 1-1 Filed 04/30/20 Page 5 of 6 PageID 34
Mergers and Resources About 3M Press
Acquisitions Releases
About 3M Factsheet
Product and
Research & REGULATORY
Brand
Development
Sustainability SDS Search
View All Transport
Releases Information
Search
RoHS &
REACH
Information
Search
CPSIA
Certi cation
Search
California
Supply
Chains Act
Disclosure
(PDF, 84KB)
UK Modern
Slavery Act
Statement
(PDF, 169KB)
More
Regulatory &
Compliance
Information
ABOUT US
About 3M
3M Careers
Investor
Relations
Partners &
Suppliers
Government
Customers
Sustainabilit
y
3Mgives
Case 8:20-cv-01003-MSS-CPT Document 1-1 Filed 04/30/20 Page 6 of 6 PageID 35
FOLLOW US
Change Location
United States - English
Legal | Privacy
© 3M 2020 . All Rights Reserved. The brands listed above are trademarks of 3M.
Business Wire NewsHQsm
File and source
- File
- gov.uscourts.flmd.376843.1.1.pdf
- Size
- 163,525 bytes
- SHA-256
- 8c82dfbd49aac3648e1af42605ebc47f70b61acbdea5ecb2bdd84e7e6f4cf77f
- Our copy
- gov.uscourts.flmd.376843.1.1.pdf
- Original
- PACER (login required)